Variational AI

Variational AI is developing Enki™, an advanced foundation model for small molecule drug discovery. This model empowers biopharmaceutical chemistry teams to efficiently discover and optimize novel hits and leads, accelerating early-stage drug discovery. Their generative AI approach aims to redefine the unit economics of drug discovery.

Funding Round: Seed+

Funding Amount: $5.5M

Date: 20-Feb-2025

Investors: Nimbus Synergies, Merck Global Health Innovation Fund, Quimby Investments, Threshold Impact, Defined Capital, Flying Fish, A&E Investment, Nepenthe Capital

Markets: AI, Biopharma, Drug Discovery

HQ: Vancouver, British Columbia, Canada

Founded: 2019

Website: https://variational.ai/

LinkedIn: https://www.linkedin.com/company/variational-ai

Twitter: https://twitter.com/VariationalAI

Instagram:

Facebook:

Crunchbase: https://www.crunchbase.com/organization/variational-ai

Pitchbook: https://pitchbook.com/profiles/company/432784-27